A Phase 1/2 of NS-050/NCNP-03 in Boys With DMD (Meteor50)
Condition: Duchenne Muscular Dystrophy Interventions: Drug: NS-050/NCNP-03; Drug: Placebo Sponsors: NS Pharma, Inc.; Nippon Shinyaku Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials